Validated risk insights
Comprehensive WGS evaluates a curated list of rigorously qualified, clinically actionable variants in up to 151 genes across 40+ health conditions.
An evidence-backed map of actionable genomic risk.
Atlas Curated Screen™ uses whole-genome sequencing (WGS) to identify genetic variants across a rigorously evidenced, curated set of genes linked to health conditions, to support proactive, personalized health decisions.
Order a test *Formerly offered as Single-Gene Risk under MyOme Proactive Health.
151 or 84
genes screened, depending on panel
40+
health conditions covered
5–6 weeks
turnaround time from samples received
Blood or buccal
sample types accepted
What Curated Screen does
Uncover actionable risks to guide lifelong health
Comprehensive whole-genome sequencing evaluates a curated list of rigorously qualified, clinically actionable variants in up to 151 genes across more than 40 health conditions. Every reported result guides personalized health decisions, like screening and lifestyle recommendations that support early detection and risk reduction.
As science advances, health changes, or tests are updated, whole-genome data can be reanalyzed for new insights — no new sample required.
Clear clinical actionability
Every reported result guides personalized health decisions, like screening and lifestyle recommendations that support early detection and risk reduction.
Lifelong reanalysis
As science advances, health changes, or tests are updated, whole-genome data can be reanalyzed for new insights — no new sample required.
Disease areas covered
The curated gene list covers 40+ health conditions
Cardiovascular conditions
Inherited cardiomyopathies and familial hypercholesterolemia.
Cancers
Hereditary breast and ovarian cancer, and hereditary colorectal cancer.
Other health conditions
Biotinidase deficiency, monogenic diabetes, and hereditary hemochromatosis.
Ordering
Two Ordering Options
When ordering, providers select the test type (Atlas Plus or Atlas Select), then choose the Curated Screen test available under that type.
Test type
Atlas Plus
Uses 30X whole-genome sequencing to detect actionable risk variants across 151 genes.
Test
Curated Screen™, 151 genes
The Curated Screen test option offered under Atlas Plus.
See what genes and diseases are includedTest code
PR21037
Test type
Atlas Select
Uses high-coverage exome plus low-coverage whole-genome sequencing to detect actionable risk variants across 84 genes.
Test
Curated Screen™, 84 genes
The Curated Screen test option offered under Atlas Select.
See what genes and diseases are includedTest code
PR22020
Interpreting results
A report built for clinical action
Because our Curated Screen test is a proactive risk screening tool performed in generally healthy individuals, we only report pathogenic and likely pathogenic variants to provide clear, clinically actionable results while avoiding unnecessary anxiety and confusion.
Result interpretation support is included in the form of clinician-to-clinician consultations for every patient.
Genetic counseling is available
MyOme offers genetic counseling to help with risk assessment and management for patients and their families.
Representative report page — not an actual patient result.
Test logistics
Intended for healthy, asymptomatic adults
Who it's for
This test is intended for healthy (asymptomatic) adults as a screening tool.
Turnaround times
From samples received, most results are delivered in 5 to 6 weeks. Follow-up testing or re-requisitions for existing MyOme patients are typically completed in under 2 weeks, often within a few days.
Sample Types Accepted
- Blood
- Buccal (cheek swab)
Turnaround times are estimates and begin once samples are processed at MyOme. They may be extended in cases outside MyOme's control, including delays related to confirmation testing or other unforeseen circumstances.
Important considerations
What Curated Screen can and cannot tell you
Patients with a personal or family history suggestive of a condition may require further screening or diagnostic genetic testing.
The test may not cover all potential genes or detect all variants associated with certain conditions. A patient may still be at risk of developing a condition even if the Curated Screen result is negative.
Genes omitted from this panel are those that do not yet meet our inclusion criteria. As data, technology, and guidelines evolve additional genes and associated conditions may be included.
Learn more
Curated Screen Resources
Genomic risk, mapped. Lifelong health, guided.
We're here at every step — from ordering and sample collection to interpreting results with your patients.